- Home
- MMD vs CDTX Comparison
MMD vs CDTX Comparison
Compare MMD & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMD
- CDTX
- Stock Information
- Founded
- MMD 2012
- CDTX 2012
- Country
- MMD United States
- CDTX United States
- Employees
- MMD N/A
- CDTX N/A
- Industry
- MMD Investment Managers
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MMD Finance
- CDTX Health Care
- Exchange
- MMD Nasdaq
- CDTX Nasdaq
- Market Cap
- MMD 279.3M
- CDTX 229.0M
- IPO Year
- MMD N/A
- CDTX 2015
- Fundamental
- Price
- MMD $15.10
- CDTX $22.18
- Analyst Decision
- MMD
- CDTX Strong Buy
- Analyst Count
- MMD 0
- CDTX 6
- Target Price
- MMD N/A
- CDTX $32.20
- AVG Volume (30 Days)
- MMD 74.7K
- CDTX 127.4K
- Earning Date
- MMD 01-01-0001
- CDTX 11-07-2024
- Dividend Yield
- MMD 4.88%
- CDTX N/A
- EPS Growth
- MMD N/A
- CDTX N/A
- EPS
- MMD N/A
- CDTX N/A
- Revenue
- MMD N/A
- CDTX $44,653,000.00
- Revenue This Year
- MMD N/A
- CDTX N/A
- Revenue Next Year
- MMD N/A
- CDTX N/A
- P/E Ratio
- MMD N/A
- CDTX N/A
- Revenue Growth
- MMD N/A
- CDTX 44.48
- 52 Week Low
- MMD $14.30
- CDTX $10.00
- 52 Week High
- MMD $17.67
- CDTX $28.42
- Technical
- Relative Strength Index (RSI)
- MMD 49.29
- CDTX 48.78
- Support Level
- MMD $14.58
- CDTX $19.87
- Resistance Level
- MMD $14.85
- CDTX $27.70
- Average True Range (ATR)
- MMD 0.19
- CDTX 2.29
- MACD
- MMD 0.06
- CDTX -0.69
- Stochastic Oscillator
- MMD 77.61
- CDTX 27.02
About MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
MainStay MacKay DefinedTerm Municipal Opportunities Fund is a USA-based diversified closed-end management investment company. The fund's investment objective is to seek current income exempt from regular U.S. Federal income taxes as well as total return. The company predominantly invests in municipal bonds, the interest on which is, in the opinion of bond counsel to the issuers, generally excludable from gross income for regular U.S. Federal income tax purposes.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.